Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in TRDA — Entrada Therapeutics, Inc.

CIK 861177 NEW YORK, NY

Position in TRDA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,201
-$2,288 QoQ
Shares Held
435
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#112
of 128 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TRDA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. TRDA ranks #180 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRDA

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,201 435
2026-03-31 $5,489 435
2025-12-31 $226 22
2025-09-30 $643 111
2025-03-31 $303,679 33,593
2024-12-31 $618,116 35,750
2024-09-30 $226,212 14,156
2024-06-30 $149,796 10,512